journal article·2017-08Open access

Scaffold requirements for periodontal regeneration with enamel matrix derivative proteins

Alessandra Apicella, Peggy Heunemann, Laurent Dejace, Matteo Marascio, Christopher J.G. Plummer, Peter Fischer

Abstract

Periodontitis affects the attachment of natural teeth, and infection or inflammation associated with periodontitis may affect peri-implant tissues. Enamel matrix derivative (EMD) proteins provide stimulation for self-regeneration of the damaged tissue when applied to wide intrabony defects as part of a mixture with bone graft material. As a first step of the process enhancing cell proliferation and ligament formation, we demonstrated that EMD protein precipitation depends strongly on the physical and chemical characteristics of the bone grafts used in the mixture. To guarantee optimum protein-stimulated self-regulation, the pH of the initial EMD formulation must therefore be adjusted between 3.9 and 4.2 in order to compensate the change in pH induced by the bone graft. Moreover, the interaction between the two components resulted in precipitates of different shape and size differently covering the grafts. This outcome might potentially have clinical implications on cell attachment and periodontal ligament extension, which deserve further in vitro and in vivo tests.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Periodontal Regeneration and Treatments · Oral microbiology and periodontitis research · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Surgical periodontal therapy with and without initial scaling and root planning in the management of chronic periodontitis: a randomized clinical trial10.1111/jcpe.12259 ↗
2. A. Apicella, P. Heunemann, 2015. Process for producing EMD of increased stability. Patent: EP3094308 A1, US20160324728 A1, WO2015106970 A1.
3. The influence of arginine on the response of Enamel Matrix Derivative (EMD) proteins to thermal stress: toward improving the stability of EMD-based products10.1371/journal.pone.0144641 ↗
4. Coordination chemistry of Ca sites at the surface of nanosized hydroxyapatite: interaction with H2O and CO10.1098/rsta.2011.0273 ↗
5. The effectiveness of enamel matrix proteins used in combination with bovine porous bone mineral in the treatment of intrabony defects in humans10.1034/j.1600-051X.2001.281105.x ↗
6. Next generation calcium phosphate-based biomaterials10.4012/dmj.28.1 ↗
7. In vitro studies of Enamel Matrix Derivative in terms of periodontal wound healing and periodontal regeneration
8. Periodontal debridement: still the treatment of choice10.1016/j.jebdp.2014.02.007 ↗
9. Patterns of protein–protein interactions in salt solutions and implications for protein crystallization10.1110/ps.072957907 ↗
10. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 201210.1902/jop.2015.140520 ↗
11. Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization10.1111/j.1600-051X.1997.tb00249.x ↗
12. Greenspan · 2013 · 1
13. Evaluation of enamel matrix derivative as an adjunct to non-surgical periodontal therapy10.1034/j.1600-051X.2003.00374.x ↗
14. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report10.1111/j.1600-051X.1997.tb00251.x ↗
15. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects10.1111/j.1600-051X.1997.tb00253.x ↗
16. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane10.1902/jop.2014.130420 ↗
17. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in human10.1902/jop.2000.71.7.1110 ↗
18. Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans10.1902/jop.2001.72.5.583 ↗
19. The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intra bony periodontal defects in humans10.1902/jop.2000.72.9.1157 ↗
20. Solvation interactions for protein adsorption to biomaterial surfaces in water
21. The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects10.14219/jada.archive.2012.0327 ↗
22. Enamel matrix proteins; old molecules for new applications10.1111/j.1601-6343.2009.01459.x ↗
23. Enamel matrix derivative and bone grafts for periodontal regeneration of intrabony defects. A systematic review and meta-analysis10.1007/s00784-015-1491-7 ↗
24. Long-term assessment of combined osseous composite grafting, root conditioning, and guided tissue regeneration
25. Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report
26. Enamel matrix derivative in combination with bone grafts: a review of the literature
27. Comparison of the capacity of enamel matrix derivative gel and enamel matrix derivative in liquid formulation to adsorb to bone grafting materials10.1902/jop.2015.140538 ↗
28. Surface characterization of bone graft substitute materials conditioned in cell culture medium10.1002/sia.3337 ↗
29. Enamel matrix proteins and systemic antibiotics as adjuncts to non-surgical periodontal treatment: clinical effects10.1111/j.1600-051X.2005.00664.x ↗
30. Preliminary staining of bacteria: negative stain
31. Enamel matrix protein derivatives: role in periodontal regeneration10.2147/CCIDE.S25347 ↗
32. A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions10.1902/jop.2002.73.8.942 ↗
33. Periodontal regeneration—intrabony defects: practical applications from the AAP Regeneration Workshop10.1902/cap.2015.140062 ↗
34. Nonsurgical treatment of periodontitis10.1016/S1532-3382(12)70019-2 ↗
35. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans10.1902/jop.2002.73.4.423 ↗
36. Bone formation in trabecular bone cell seeded scaffolds used for reconstruction of the rat mandible10.1016/j.ijom.2008.11.018 ↗
37. Arginine and Hofmeister series: the role of ion-ion interactions in protein aggregation suppression10.1021/jp111920y ↗
38. Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans
39. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans10.1902/jop.2002.73.4.401 ↗
40. Clinical and histologic evaluation of human intra-bony defects treated with an enamel matrix protein derivativecombined with a bovine-derived xenograft
41. A systematic review on the clinical efficacy of subgingival debridement in the treatment of chronic periodontitis10.1034/j.1600-051X.29.s3.3.x ↗
42. Weinreb · 2017 · 109
43. Periodontal wound healing and regeneration10.1111/j.1600-0757.1999.tb00145.x ↗